Skip to content

Asymmetric Di-Methyl Arginine (ADMA) Recombinant Rabbit Monoclonal Antibody [PSH09-55]

Usd: 385

Specification

Bulk Order Quote | Customization Request

Catalog# HA723117

Asymmetric Di-Methyl Arginine (ADMA) Recombinant Rabbit Monoclonal Antibody [PSH09-55]

Application

  • ELISA

  • WB

Reactivity

  • Species independent

BSA and Azide free
Conjugation

  • unconjugated

Overview

Product Name

Asymmetric Di-Methyl Arginine (ADMA) Recombinant Rabbit Monoclonal Antibody [PSH09-55]

Antibody Type

Recombinant Rabbit monoclonal Antibody

Immunogen

Immunogen Asymmetric Dimethylarginine (ADMA) KLH-conjugated

Species Reactivity

Species independent

Validated Applications

ELISA, WB

Conjugation

unconjugated

Clone Number

PSH09-55

Reactivity Data

ELISA WB
Species Independent
Tested Tested

Product Features

Form

Liquid

Concentration

Storage Instructions

Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.

Storage Buffer

PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.

Isotype

IgG

Purification Method

Protein A affinity purified.

Application Dilution

  • ELISA

  • 1:2,000

  • WB

  • 1:2,000

Target

Function

Arginine methylation is a prevalent posttranslational modification which is deposited by a family of protein arginine methyltransferases (PRMTs), and is found in three different forms in mammalian cells: mono-methylarginine (MMA), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Pan-methylarginine antibodies are critical for identifying proteins that are methylated on arginine residues, and are also used for evaluating signaling pathways that modulate this methyltransferase activity.

Background References

1. Wu Y et al. Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis. Sci Adv. 2023 Feb

2. Ozkarafakili MA et al. Asymmetric Dimethylarginine in COPD Exacerbation. Sisli Etfal Hastan Tip Bul. 2022 Dec

Synonyms

ADMA antibody

Asymmetrical Dimethylarginine antibody

Asymmetric Di-Methyl Arginine antibody

Images

  • <span style="font-weight: bold;">☑ Cell treatment (CT)</span><br /><br />Western blot analysis of Asymmetric Di-Methyl Arginine (ADMA) on different lysates with Rabbit anti-Asymmetric Di-Methyl Arginine (ADMA) antibody (<a href="/products/HA723117" style="font-weight: bold;text-decoration: underline;">HA723117</a>) at 1/2,000 dilution.<br /><br />Lane 1: 293T cell lysate<br />Lane 2: 293T treated with 10nM Type I PRMT inhibitor MS023 for 48 hours cell lysate<br /><br />Lysates/proteins at 30 µg/Lane.<br /><br />Exposure time: 1 minute 22 seconds; ECL: K1802;<br /><br />4-20% SDS-PAGE gel.<br /><br />Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (<a href="/products/HA723117" style="font-weight: bold;text-decoration: underline;">HA723117</a>) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (<a href="/products/HA1001" style="font-weight: bold;text-decoration: underline;">HA1001</a>) at 1/50,000 dilution was used for 1 hour at room temperature.

    ☑ Cell treatment (CT)

    Western blot analysis of Asymmetric Di-Methyl Arginine (ADMA) on different lysates with Rabbit anti-Asymmetric Di-Methyl Arginine (ADMA) antibody (HA723117) at 1/2,000 dilution.

    Lane 1: 293T cell lysate
    Lane 2: 293T treated with 10nM Type I PRMT inhibitor MS023 for 48 hours cell lysate

    Lysates/proteins at 30 µg/Lane.

    Exposure time: 1 minute 22 seconds; ECL: K1802;

    4-20% SDS-PAGE gel.

    Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723117) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.

  • Western blot analysis of Asymmetric Di-Methyl Arginine (ADMA) on different lysates with Rabbit anti-Asymmetric Di-Methyl Arginine (ADMA) antibody (<a href="/products/HA723117" style="font-weight: bold;text-decoration: underline;">HA723117</a>) at 1/2,000 dilution.<br /><br />Lane 1: MCF7 cell lysate (20 µg/Lane)<br />Lane 2: Mouse brain tissue lysate (40 µg/Lane)<br />Lane 3: Mouse liver tissue lysate (40 µg/Lane)<br />Lane 4: Rat brain tissue lysate (40 µg/Lane)<br /><br />Exposure time: 3 minutes; ECL: K1802;<br /><br />4-20% SDS-PAGE gel.<br /><br />Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (<a href="/products/HA723117" style="font-weight: bold;text-decoration: underline;">HA723117</a>) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (<a href="/products/HA1001" style="font-weight: bold;text-decoration: underline;">HA1001</a>) at 1/50,000 dilution was used for 1 hour at room temperature.

    Western blot analysis of Asymmetric Di-Methyl Arginine (ADMA) on different lysates with Rabbit anti-Asymmetric Di-Methyl Arginine (ADMA) antibody (HA723117) at 1/2,000 dilution.

    Lane 1: MCF7 cell lysate (20 µg/Lane)
    Lane 2: Mouse brain tissue lysate (40 µg/Lane)
    Lane 3: Mouse liver tissue lysate (40 µg/Lane)
    Lane 4: Rat brain tissue lysate (40 µg/Lane)

    Exposure time: 3 minutes; ECL: K1802;

    4-20% SDS-PAGE gel.

    Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723117) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.

  • Indirect ELISA analysis of ADMA.

    Indirect ELISA analysis of ADMA.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"